Cargando…
Breaking androgen receptor addiction of prostate cancer by targeting different functional domains in the treatment of advanced disease
In the last decade, treatment for castration-resistant prostate cancer has changed markedly, impacting symptom control and longevity for patients. However, a large proportion of cases progress despite androgen deprivation therapy and chemotherapy, while still being fit enough for several more lines...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138777/ https://www.ncbi.nlm.nih.gov/pubmed/33993099 http://dx.doi.org/10.1016/j.tranon.2021.101115 |